AI
Utah Built the Clinical AI Sandbox Founders Are Racing Toward
If you're building clinical AI and haven't looked at Utah, you're late.
Latest — Page 32
Legal
ESMA Orders Unlicensed Crypto Firms Out of EU Markets by July 1
The European Securities and Markets Authority confirmed April 17 that MiCA's transitional grace period closes July 1 — any firm offering crypto-asset…
FDA
Paid $5.76B: Merck's Keytruda Triplet Fails Both RCC Endpoints
Merck and Eisai's Phase 3 LITESPARK-012 study failed Tuesday.
AI
Adobe Ditches Token Pricing for AI, Charges by Outcome Now
Adobe CX Enterprise will price by ad campaigns completed, not tokens burned. The contract dispute template for outcome AI doesn't exist yet.
ai
AI
Google Wires Gemini AI Into Chrome's 3 Billion Users Overnight
Agentic AI just hit gatekeeper distribution. Chrome's Gemini rollout runs straight into DSA, DMA, and FTC questions the field hasn't answered.
ai
AI
Lloyds Picks DBS's Sameer Gupta as First Chief AI Officer, June Start
Lloyds hires DBS's Sameer Gupta to run AI from June. The UK bank AI officer arms race is on, and PRA's SS1/23 is the subtext.
ai
AI
UnitedHealth Pours $1.5B Into AI, Expects $3B Back in 18 Months
UnitedHealth's Q1 AI math: spend $1.5B, scale Optum Real to 2.5B transactions, book 2-to-1 back inside 18 months.
ai
AI
Utah Cleared Doctronic for AI Prescription Refills. Who's Next?
A couple of months ago, Utah allowed startup Doctronic to use AI to refill prescriptions.
Legal
Sued Over Prediction Markets, Coinbase and Gemini Push Back
New York's Office of the Attorney General sued Coinbase and Gemini in state court Tuesday, charging both companies with operating illegal, unlicensed…
Legal
PACE Act Cuts 40-State License Requirement for Payment Fintechs
Two House members introduced the Payments Access and Consumer Efficiency (PACE) Act on April 21, giving nonbank payment service providers a federal path to…
FDA
Roche Fenebrutinib Clears Phase 3, Carries 8-to-1 Death Gap
Roche's fenebrutinib posted eight deaths against Aubagio's one across its two phase 3 relapsing MS trials, and at the American Academy of Neurology Annual…
FDA
Replimune cuts 224 jobs after FDA's second RP1 rejection
FDA rejected Replimune's RP1 for advanced melanoma a second time, and 224 Massachusetts employees are now paying for it.
FDA
NC Biotech Gathers CAR-T Crowd at UNC Friday After $7B Kelonia Deal
CAR-T makers hit UNC Chapel Hill Friday, five days after Lilly's $7B Kelonia bet turned the CMC question into the deal question.
fda
FDA
Roche MS Pill Doubles Relapse-Free Time, Flags Liver Risk
Roche's multiple sclerosis pill more than doubled patients' relapse-free intervals compared with Sanofi's marketed MS pill Aubagio, according to data…
AI
Questioned by 2 Lawmakers, JetBlue Faces AI Pricing Probe
Two lawmakers sent JetBlue a formal letter on April 20 demanding answers about whether the airline uses AI and customer data to set prices.
